Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Thymoma and PIK3CA[original query] |
---|
AKT1 and AKT2 mutations in lung cancer in a Japanese population. Molecular medicine reports 0 1 (5): 663-6. Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita |
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71. Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife |
MEK1 and AKT2 mutations in Japanese lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Mar . Sasaki H, Hikosaka Y, Kawano O, Moriyama S, Yano M, Fujii Y |
Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma. Oral oncology 2011 Oct 47 (10): 946-50. Cohen Yoram, Goldenberg-Cohen Nitza, Shalmon Bruria, Shani Tali, Oren Shirley, Amariglio Ninette, Dratviman-Storobinsky Olga, Shnaiderman-Shapiro Anna, Yahalom Ran, Kaplan Ilana, Hirshberg Abrah |
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Human pathology 2012 Oct 43 (10): 1573-82. Juanpere Nuria, Agell Laia, Lorenzo Marta, de Muga Silvia, López-Vilaró Laura, Murillo Raquel, Mojal Sergi, Serrano Sergio, Lorente José A, Lloreta Josep, Hernández Silv |
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice. The oncologist 2014 May 19 (5): 453-8. Vasan Neil, Yelensky Roman, Wang Kai, Moulder Stacy, Dzimitrowicz Hannah, Avritscher Rony, Wang Baliang, Wu Yun, Cronin Maureen T, Palmer Gary, Symmans W Fraser, Miller Vincent A, Stephens Philip, Pusztai Laj |
A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer. Journal of cancer research and clinical oncology 2014 Aug 140 (8): 1399-411. Wang Xiaoting, Lin Youdong, Lan Fenghua, Yu Yinghao, Ouyang Xuenong, Wang Xuzhou, Huang Qiaojia, Wang Lie, Tan Jianming, Zheng Fe |
Rare frequency of gene variation and survival analysis in thymic epithelial tumors. OncoTargets and therapy 2016 9 6337-6342. Song Zhengbo, Yu Xinmin, Zhang Yipi |
Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA. International journal of oral and maxillofacial surgery 2016 Jan . Shalmon B, Drendel M, Wolf M, Hirshberg A, Cohen |
A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 2019 Jun . Sakane Tadashi, Murase Takayuki, Okuda Katsuhiro, Saida Kosuke, Masaki Ayako, Yamada Takeshi, Saito Yushi, Nakanishi Ryoichi, Inagaki Hiros |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: